APH1A is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains APH1A status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

BRAF is an inclusion eligibility criterion in 2 clinical trials for colon carcinoma, of which 1 is open and 1 is closed. Of the trials that contain BRAF status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) and 1 is phase 1/phase 2 (1 open) [3].

DLL4 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains DLL4 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

FBXW7 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains FBXW7 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

JAG1 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains JAG1 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

KRAS is an inclusion eligibility criterion in 3 clinical trials for colon carcinoma, of which 2 are open and 1 is closed. Of the trials that contain KRAS status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) and 2 are phase 1/phase 2 (2 open) [3].

MAML1 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains MAML1 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NCSTN is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NCSTN status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NOTCH1 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NOTCH2 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH2 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NOTCH3 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH3 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NOTCH4 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH4 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].

NRAS is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 1 is open and 0 are closed. Of the trial that contains NRAS status and colon carcinoma as inclusion criteria, 1 is phase 1/phase 2 (1 open) [3].

PIK3CA is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 1 is open and 0 are closed. Of the trial that contains PIK3CA status and colon carcinoma as inclusion criteria, 1 is phase 3 (1 open) [3].

PIK3R1 is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 1 is open and 0 are closed. Of the trial that contains PIK3R1 status and colon carcinoma as inclusion criteria, 1 is phase 3 (1 open) [3].

PTEN is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 1 is open and 0 are closed. Of the trial that contains PTEN status and colon carcinoma as inclusion criteria, 1 is phase 3 (1 open) [3].

WNT5A is an inclusion eligibility criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains WNT5A status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [3].